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Abstract  30	
Background: In obesity, improved muscle insulin sensitivity following exercise training has been 31	
linked to the lowering of diacylglycerol (DAG) and ceramide concentrations.  Little is known, however, 32	
about how improved insulin action with exercise training in obese individuals relates to lipid droplet 33	
(LD) adaptations in skeletal muscle.  In this study we investigated the hypothesis that short-term sprint 34	
interval training (SIT) and moderate intensity continuous training (MICT) in obese individuals would 35	
increase perilipin (PLIN) expression, increase the proportion of LDs in contact with mitochondria and 36	
reduce muscle concentrations of DAGs and ceramides.   37	
Methods: Sixteen sedentary obese males performed 4 weeks of either SIT (4-7x 30s sprints at 200% 38	
Wmax, 3 days.week-1) or MICT (40-60 min cycling at ~65% VO2peak, 5 days.week-1), and muscle biopsies 39	
were obtained pre- and post-training.   40	
Results: Training increased PLIN2 (SIT 90%, MICT 68%) and PLIN5 (SIT 47%, MICT 34%) 41	
expression in type I fibres only, and increased PLIN3 expression in both type I (SIT 63%, MICT 67%) 42	
and type II fibres (SIT 70%, MICT 160%) (all P<0.05).  Training did not change LD content but 43	
increased the proportion of LD in contact with mitochondria (SIT 12%, MICT 21%, P<0.01).  44	
Ceramides were reduced following training (SIT -10%, MICT -7%, P<0.05), but DAG was unchanged.  45	
No training × group interactions were observed for any variables.  46	
Conclusions: These results confirm the hypothesis that SIT and MICT results in remodelling of LDs 47	
and lowers ceramide concentrations in skeletal muscle of sedentary obese males.   48	
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Introduction 49	
Intramuscular triglyceride (IMTG) accumulation in sedentary and obese individuals is associated with 50	
low skeletal muscle insulin sensitivity and an increased risk of developing type 2 diabetes1, 2.  However, 51	
endurance-trained athletes store even larger quantities of IMTG while exhibiting high levels of insulin 52	
sensitivity.  This phenomenon is termed the athlete's paradox1, 3.  Subsequently, it has been proposed 53	
that lipid metabolites such as diacylglycerols (DAG) and ceramides play a key role in the development 54	
of insulin resistance rather than IMTG4, 5.  Indeed, evidence from cell culture and animal models 55	
demonstrates that elevated DAG6 or ceramides7 directly impair insulin signalling.  Evidence from 56	
human studies is less clear, with some7-11, but not all12-15 studies reporting higher DAG and ceramide 57	
concentrations in skeletal muscle of insulin resistant obese and/or type 2 diabetes patients compared to 58	
healthy, insulin-sensitive individuals.  Investigations exploring the degree of saturation and specific 59	
fatty acid composition of these lipids may unravel their specific role in the development of insulin 60	
resistance. 61	
 62	
To date, few studies have evaluated the effect of longitudinal exercise training interventions on muscle 63	
DAGs and ceramides.  A number of studies have reported reductions in ceramide concentrations16-18, 64	
whereas the concentration of DAGs has been shown to decrease17, 18 or remain unchanged16, 19 following 65	
training.  Importantly, these studies have only investigated the effect of moderate-intensity continuous 66	
training (MICT).  Sprint interval training (SIT) has gained increased attention as it can increase skeletal 67	
muscle oxidative capacity and improve whole-body insulin sensitivity with substantial reductions in 68	
time commitment and total training workload, compared to MICT20-23.  Therefore, SIT offers promise 69	
as an alternative to continuous moderate-intensity exercise training to prevent and treat metabolic 70	
disease.  This is the first study to investigate whether improvements in insulin sensitivity following SIT 71	
occur alongside reductions in DAG and ceramide concentrations. 72	
 73	
IMTG are stored in lipid droplets (LD), the majority of which are in close spatial contact with the 74	
mitochondrial network in endurance-trained individuals24, 25.  Over 300 proteins are associated with the 75	
LD 26, the most abundant of which are the perilipin (PLIN) family of proteins.   It is generally accepted 76	
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that PLIN2 and PLIN5 promote IMTG storage27, since overexpression of either protein augments IMTG 77	
content in skeletal muscle while keeping insulin sensitivity high28, 29.  PLIN5 knock-out on the other 78	
hand results in elevated ceramide concentrations and lower insulin-mediated glucose disposal rates30, 79	
highlighting the importance of PLIN5 for maintaining high levels of insulin sensitivity.  We recently 80	
reported that improvements in insulin sensitivity in sedentary lean individuals following SIT occur 81	
alongside increases in IMTG storage and greater expression of PLIN2 and PLIN522.  At present, 82	
however, it is not known whether exercise training-induced increases in the abundance of the PLIN 83	
proteins contributes to improvements in insulin sensitivity, via decreases in DAG and ceramide content, 84	
in obese individuals at risk of developing metabolic syndrome.  85	
 86	
Less attention has been paid to PLIN3, despite this protein also being highly expressed in skeletal 87	
muscle31.  Fatty acid packaging in LD is reduced when PLIN3 is ablated in fibroblastic cells32, 88	
suggesting that PLIN3 is important for triacylglycerol storage.  PLIN3 may also play a role in 89	
triacylglycerol oxidation, since skeletal muscle PLIN3 content is positively associated with whole-body 90	
fat oxidation33 and ex vivo palmitate oxidation33, 34.  Data on the effect of MICT on skeletal muscle 91	
PLIN3 content, measured through immunoblotting of whole muscle homogenates, are contradictory 92	
with both an increase19 and no change35 being reported in obese individuals.  Part of this contradiction 93	
could be the consequence of muscle fibre type differences. Using quantitative immunofluorescence 94	
microscopy methods in combination with identification of muscle fibre type36 we previously reported 95	
that 6 months of MICT in type 2 diabetes patients increased PLIN2 expression in type 1 fibres only37, 96	
highlighting the importance of considering fibre type when investigating exercise training adaptations.   97	
 98	
In the current study, we used muscle fibre type-specific methods to investigate the hypothesis that SIT 99	
and MICT in obese individuals would augment protein expression of PLIN2, PLIN3, and PLIN5.  We 100	
also employed transmission electron microscopy to assess mitochondrial density and the proportion of 101	
LD in direct contact with mitochondria within the muscle fibre.  Finally, measurements of total and 102	
subspecies of DAGs and ceramides were made to test the hypothesis that SIT and MICT would also 103	
lower the concentration of these lipid metabolites in muscle.   104	
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Materials and Methods 105	
Participants and ethical approval 106	
The samples collected in this study have been used in a previous publication which focused on the 107	
effects of SIT and MICT on microvascular adaptations in skeletal muscle38.  Brief subject 108	
characteristics, including body composition, exercise capacity and insulin sensitivity are also presented 109	
in Table 1 in this paper.  Sixteen young, sedentary obese males (25±1 y, 34.8±0.9 kg.m-2), who were 110	
engaging in less than one hour of structured physical activity per week, and were free of known 111	
metabolic or cardiovascular disorders, as determined by a medical professional during a pre-study 112	
screening visit, provided written informed consent.  Two participants had impaired fasting glucose 113	
(fasting plasma glucose ≥6.1 mmol.L-1; SIT n=1, MICT n=1) and four subjects had impaired fasting 114	
glucose and impaired glucose tolerance (2 h oral glucose tolerance concentration between 7.8 and 11.1 115	
mmol.L-1; SIT n=2, MICT n=2).  The study protocol adhered to the Declaration of Helsinki and was 116	
approved by the South Birmingham NHS Research Ethics Committee.   117	
 118	
Pre- and post-training experimental procedures 119	
Experimental procedures, including measures of aerobic capacity (VO2peak), body composition and 120	
insulin sensitivity, were undertaken before and after training (>48 h following the final exercise training 121	
session and identical in all respects to pre-training) as previously described38.  Muscle samples (~100 122	
mg) were obtained from the vastus lateralis under local anaesthesia using the Bergström technique39 123	
following an overnight fast.  The biopsy was separated and preserved for immunofluorescence 124	
microscopy, transmission electron microscopy, and analysis of lipid species.  Following the pre-training 125	
experimental procedures the 16 subjects were divided into pairs matched for age, BMI and VO2peak, 126	
with one member from each pair randomly assigned to either the SIT or MICT group. 127	
 128	
Training procedures 129	
Sprint interval training (SIT):  Subjects performed repeated 30 s sprints on a cycle ergometer against a 130	
constant load equivalent to 200% Wmax, interspersed with 2 min recovery during which subjects cycled 131	
against a small load (30 W) maintaining a cadence of <50 rpm.  Subjects trained three times per week 132	
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for four weeks.  Exclusion criteria stated that subjects would be excluded if they were absent from more 133	
than two sessions.  However, no subjects needed to be excluded on this basis.  Four sprints per training 134	
session were performed in week one, after which an additional sprint was included on each consecutive 135	
week, such that seven sprints were performed per training session in week four.  Heart rate was recorded 136	
throughout each session. 137	
 138	
Moderate-intensity continuous training (MICT):  Subjects in the MICT group trained 5 times per week 139	
over the 4 week training period, and were excluded from the study if they were absent from more than 140	
two training sessions.  All subjects cycled at a workload equivalent to ~65% VO2peak for 40 min during 141	
the first seven sessions, increasing to 50 min during sessions 8 to 14, and 60 minutes during sessions 142	
15 to 20.  VO2peak was reassessed after two weeks of training and workload adjusted accordingly. 143	
 144	
Immunofluorescence microscopy 145	
Muscle tissue was prepared for immunohistochemical analysis by embedding in Tissue-Tek OCT 146	
Compound (Sakura Finetek Europe, The Netherlands) and freezing in liquid nitrogen-cooled 147	
isopentane.  Serial 5 µm cryosections were cut at -30°C and transferred on to ethanol-cleaned glass 148	
slides.  The neutral lipid dye oil red O was used to image and quantify IMTG40.  All primary and 149	
secondary antibodies for immunofluorescence microscopy have been used previously22, 24, 36 except for 150	
the PLIN3 primary antibody (guinea pig polyclonal anti-TIP47, GP30, Progen Biotechnik, Germany).  151	
Training-induced changes in fibre-specific PLIN2, PLIN3 and PLIN5 content, and COX expression (as 152	
a marker of muscle oxidative capacity) were assessed using established and validated widefield and 153	
confocal immunofluorescence microscopy techniques22, 24, 36.  Image processing was undertaken using 154	
Image-Pro Plus 5.1 software (Media Cybernetics, MD, USA).  A total of 97±9 cross-sectionally 155	
orientated fibres from a muscle section (38±4 type I fibres, 59±6 type II fibres) were analysed for each 156	
variable.  Fluorescence staining intensity was used to indicate training-induced changes in COX 157	
expression.  IMTG, PLIN2, PLIN3 and PLIN5 content were expressed as the positively stained area 158	
fraction relative to the total area of each muscle fibre.  For all fibre type-specific analyses, fibres stained 159	
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positively for myosin heavy chain type 1 were classified as type I muscle fibres, whereas all other fibres 160	
were assumed to be type II muscle fibres.      161	
 162	
Transmission electron microscopy 163	
Fresh muscle tissue was immediately fixed with 2.5% glutaraldehyde in 0.1 M sodium cacodylate buffer 164	
(pH 7.3) for 24 h, followed by four rinses in 0.1 M sodium cacodylate buffer.  Secondary fixation was 165	
undertaken with 1% osmium tetroxide (Agar Scientific, Essex, UK) for 1 h, followed by two rinses in 166	
0.1 M sodium cacodylate buffer.  Muscle tissue was subsequently dehydrated using increasing 167	
concentrations of alcohol (50, 70, 90, and 100%), followed by exposure to propylene oxide (Agar 168	
Scientific, Essex, UK).  Dehydrated tissue was incubated in a propylene oxide/resin (1:1) and then 169	
embedded in 100% Mollenhauer resin (polymerised for >16 h at 60°C) (Agar Scientific, Essex, UK).  170	
Resin blocks (with tissue embedded) were trimmed and 1 µm sections were prepared to check fibre 171	
orientation.  Longitudinal orientated ultra-thin sections (100 nm) were obtained using an 172	
ultramicrotome (Reichert Jung Ultracut, Vienna, Austria) fitted with a diamond blade and collected on 173	
to a formvar coated microscope grid (200 copper mesh size), followed by staining with uranyl acetate 174	
and lead citrate.   175	
 176	
Sections were viewed and photographed at x10,000 magnification using a Jeol 1200 Ex transmission 177	
electron microscope (TEM) (Jeol, Tokyo, Japan) with a Megaview III FW camera.  Four micrographs 178	
of the intermyofibrillar region per fibre from four different muscle fibres per time point (i.e. 16 179	
micrographs per time point per person, 32 micrographs in total) were obtained in a randomized 180	
systematic manner.  Micrograph analysis was undertaken using Image-Pro Plus 5.1 software (Media 181	
Cybernetics, MD, USA).  A grid with squares of 500x500 nm (0.25 µm2) was superimposed on to each 182	
micrograph, and the number of points (two intersecting grid lines) that were in contact with 183	
mitochondria or LD was summed and expressed relative to the total number of points on the grid 184	
(corresponding to a total of 784 points).  This grid size was selected in line with a recent study that 185	
aimed to standardise the grid size used across studies41.  This process was undertaken for each 186	
micrograph and the values averaged to calculate mitochondria or LD volume density (expressed as % 187	
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area of muscle occupied by mitochondria or LDs).  Individual mitochondria and LDs were isolated 188	
using the ‘area of interest’ tool in the Image-Pro Plus software and mean individual mitochondria and 189	
LD size (µm2) was subsequently determined.  The total number of mitochondria or LDs was expressed 190	
per square micrometer of tissue (#.µm2 tissue-1).  The number of LDs in contact with mitochondria was 191	
manually counted and expressed as a percentage of the total number of LDs per micrograph.  192	
Acquisition and analysis of all micrographs was performed blinded to subject, condition and time-point.   193	
 194	
Lipid composition analysis 195	
Approximately 20 mg of muscle tissue was used for the lipid composition analysis.  Muscle lipids were 196	
extracted using a single-phase chloroform/methanol extraction. Triacylglycerol (TAG), DAG, 197	
ceramide, monohexosylceramide (MHC) dihexosylceramide (DHC), trihexosylceramide (THC), 198	
sphingomyelin (SM), gangliomyelin (GM) were analysed using electrospray ionization-tandem mass 199	
spectrometry, as previously described42.  The concentration of each lipid specie was expressed relative 200	
to the concentration of total PC43, and was then used to calculate a fold change (relative to the value for 201	
MICT Pre43).   202	
 203	
Statistics 204	
Training-induced changes in TEM LD and mitochondria measures and muscle lipid species were 205	
assessed using a two-factor repeated measures ANOVA.  A three-factor repeated measures ANOVA 206	
was used to examine fibre-specific training-induced changes in IMTG, PLIN2, PLIN3, PLIN5 and COX 207	
content.  Significant interactions obtained during repeated measures ANOVA were investigated using 208	
Bonferroni adjustment post hoc analysis.  Pearson’s bivariate correlation analysis was used to 209	
investigate specific relationships between variables.  All data are expressed as means ± S.E.M.  The 210	
sample size was deemed sufficient to detect a within-group training effect of f=0.30 (representative of 211	
a medium-effect size44) for PLIN protein content, adopting an alpha of 0.05 and a power of 80%.  This 212	
was calculated using G*Power 3.1 software (G*Power Software Inc., Kiel, Germany), and was based 213	
on our previous observation that PLIN protein content was significantly increased following 6 weeks 214	
of SIT and MICT in lean sedentary individuals22.  215	
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Results 216	
Exercise capacity, body composition and insulin sensitivity (Table 1) 217	
As we have previously reported38, VO2peak was increased by both SIT (13%) and MICT (10%), with no 218	
difference between groups (main training effect; P=0.002).  Fat mass (-5%) and percentage body fat (-219	
4%) were both reduced by MICT only (training × group interaction; P<0.05), with no change observed 220	
following SIT.  Insulin sensitivity, as measured by the Matsuda index, was increased by both SIT (11%) 221	
and MICT (24%), with no significant difference between groups.  222	
 223	
Immunofluorescence microscopy analysis 224	
Muscle fibre type-specific COX expression (expressed as mean fluorescence intensity) was greater in 225	
type I compared to type II fibres both pre and post-training (P<0.01, Fig. 1A-B & Supplementary Fig. 226	
S1).  Training increased COX expression in both type I (SIT 29%, MICT 36%) and type II fibres (SIT 227	
49%, MICT 36%; main training effect, P<0.01, Fig. Fig. 1A-B & Supplementary Fig. S1), with no 228	
difference between groups.  IMTG content (expressed as % area stained) was higher in type I versus 229	
type II muscle fibres both pre and post-training (P<0.01, Fig. 1C-D & 2).  The increase in IMTG content 230	
in response to training both in type I (SIT 26%, MICT 22%) and type II fibres (SIT 35%, MICT 26%; 231	
Fig. 1C-D & 2) did not reach statistical significance (P=0.1).  PLIN2, PLIN3 and PLIN5 content 232	
(expressed as % area stained) was greater in type I compared to type II fibres (P<0.01, Fig. 1E-J & 2) 233	
across all time points.  In response to training PLIN2 content increased, although this only reached 234	
significance in type I fibres (SIT 90%, MICT 68%; training × fibre interaction, P<0.001, Fig. 1E & 2).  235	
In contrast, PLIN3 content increased following training in both type I (SIT 63%, MICT 67%, Fig. 1G 236	
& 2) and type II fibres (SIT 70%, MICT 160%; main training effect, P<0.01, Fig. 1H & 2).  Training 237	
led to an increase in PLIN5 content in type I fibres only (SIT 47%, MICT 34%; training × fibre 238	
interaction, P<0.01, Fig. 1I & 2).  PLIN2, PLIN3 and PLIN5 expression was not different between the 239	
two training interventions at any time point. 240	
 241	
 242	
 243	
10 
	
Transmission electron microscopy analysis  244	
Training induced a significant increase in mitochondrial volume density (expressed as % area of 245	
muscle) (SIT 46%, MICT 88%; main training effect, P<0.01, Fig. 3D), with no difference between 246	
groups.  This increase was attributed to a greater number of mitochondria (SIT 33%, MICT 20%; main 247	
training effect, P=0.01, Fig. 3E) and increased mitochondrial size (SIT 27%, MICT 51%; main training 248	
effect, P<0.01, Fig. 3F), with no difference between groups.  In contrast, no significant changes were 249	
observed in LD volume density, LD number or LD size in response to training (P>0.05, Fig. 3H-J).  250	
However, there was an increase in the proportion of LDs in contact with mitochondria following 251	
training (SIT 12%, MICT 21%; main training effect, P<0.01, Fig. 1G), with no difference between 252	
groups.  Examples of LDs in contact and not in contact with mitochondria are provided in Fig. 3B-C. 253	
 254	
Muscle TAG, DAG and sphingolipids 255	
Training did not change the concentration of total TAG (P>0.05, Fig. 4) or specific TAG subspecies 256	
(data not shown).  There was also no change in total DAG concentrations with training (P>0.05, Fig. 257	
4), however there was a significant increase in DAG 18:1/18:2 (main training effect, P=0.02) and DAG 258	
18:0/18:2 (main training effect, P=0.04, Fig. 5A). Training induced a significant decrease in total 259	
ceramide content (SIT -10%, MICT -7%; main training effect, P=0.03, Fig. 4), with no difference 260	
between groups.  Further examination of the specific ceramide species revealed that training led to a 261	
significant decrease in Cer 18:0 (P=0.01, Fig. 5C).  We also examined the effect of training on other 262	
complex ceramides and sphingomyelin, and found that training led to an increase in total 263	
trihexosylceramide (THC) concentration (SIT 32%, MICT 10%; main training effect, P=0.02, Fig. 5B), 264	
with no difference between groups.  The THC species THC 24:0 and THC 24:1 were the only species 265	
that significantly increased in response to training (both P<0.01, Fig. 5D). 266	
 267	
Correlation analysis 268	
Given the lack of group × training interactions in muscle variables, significant training effects were 269	
detected independent of exercise modality.  Therefore, the data from the two intervention groups were 270	
pooled for correlation analysis.  The proportion of LDs touching mitochondria correlated positively 271	
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with expression of PLIN2 (R=0.67; P<0.001), PLIN3 (R=0.39; P=0.049) and PLIN5 (R=0.43; P=0.028) 272	
in muscle.  Muscle ceramide levels were also related to PLIN expression, demonstrating a moderate 273	
negative correlation with PLIN2 (R=-0.41; P=0.029), PLIN3 (R=-0.49; P=0.008) and PLIN5 expression 274	
(R=-0.39; P=0.039).  Finally, a significant negative relationship between muscle Cer18:0 levels and 275	
PLIN2 expression (R=-0.44; P=0.036) was observed, but this did not reach significance when muscle 276	
Cer18:0 levels were related to PLIN3 (R=-0.39; P=0.068) or PLIN5 (R=-0.41; P=0.052) content.  277	
Whole-body insulin sensitivity was not significantly related to any muscle variables.  278	
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Discussion  279	
In the present study we demonstrate for the first time that in previously sedentary obese males, a short-280	
term SIT and MICT intervention both lead to 1) a reduction in muscle ceramide concentrations, 2) an 281	
increase in the number of LDs in contact with mitochondria, and 3) muscle fibre-specific increases in 282	
PLIN2, PLIN3 and PLIN5.  Importantly, these adaptations were comparable in response to both SIT 283	
and MICT interventions. 284	
 285	
The first novel finding of the present study was that 4 weeks of either SIT or MICT significantly reduced 286	
muscle ceramide concentrations in obese individuals.  Reductions in muscle ceramide concentrations 287	
have previously been reported following 8-16 weeks endurance training in obese individuals16, 18, and 288	
we now extend the ceramide-lowering effect of exercise training to include SIT.  Further analysis 289	
revealed that training specifically lowered Cer18:0.  This may be an important adaptation, since it has 290	
recently been reported in humans that the muscle concentration of Cer18:0 is inversely related to insulin 291	
sensitivity45.  Ceramides are elevated in the muscle of insulin resistant populations7, 9-12 and are a potent 292	
inhibitor of muscle insulin action through the activation of the phosphatase PP2A and subsequent 293	
dephosphorylation and inhibition of Akt46.  Therefore, it is feasible that the reduction in ceramide 294	
concentrations, and particularly Cer18:0, observed following training may contribute to the improved 295	
whole-body insulin sensitivity observed in response to SIT and MICT38.  We also observed a significant 296	
increase in total skeletal muscle THC concentration, with increases occurring in the THC 24:0 and THC 297	
24:1 species.   The relevance of THC to insulin sensitivity is not clear and warrants further investigation.   298	
 299	
Contrary to our hypothesis, we did not detect a change in total DAG content but rather an increase in 300	
specific DAG species following training (DAG 18:1/18:2 and DAG 18:0/18:2).  Although previous 301	
studies and reviews have heavily implicated DAG in the pathogenesis of insulin resistance4, 6, 8, the 302	
relationship between muscle DAG and insulin sensitivity has proved complex. Our results are in line 303	
with a number of studies that have demonstrated a disconnect between muscle DAG content and insulin 304	
sensitivity (reviewed by 47). Most notably, Amati et al.12, demonstrated that trained individuals 305	
displayed higher DAG levels than sedentary lean and obese individuals. Therefore, it appears that 306	
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changes in DAG concentrations may not be directly relevant for the improvements in insulin sensitivity 307	
following exercise training. 308	
 309	
The second novel finding of the study is that short-term SIT led to an increase in the number of LDs 310	
that are in contact with mitochondria.  In line with this observation, it has been reported previously that 311	
6-12 weeks of MICT augments the number of LDs in contact with mitochondria in both lean25 and 312	
obese48 individuals.  This is likely to be an important adaptation, because a large proportion of 313	
extracellular FAs flux through the IMTG pool prior to oxidation in the mitochondria49, and therefore 314	
the contact of LDs with mitochondria is important to efficiently channel FA released by IMTG lipolysis 315	
into the mitochondrial reticulum for oxidation50.  Thus, the greater number of LDs in contact with 316	
mitochondria will aid in the efficient transfer of LD-derived FAs to the mitochondria and contribute to 317	
the well described increase in IMTG-derived FA oxidation following exercise training. The greater 318	
COX expression following training would also support this by providing a greater oxidative 319	
phosphorylation capacity in both type I and type II fibres.  Such an improvement in the channelling of 320	
FA’s towards oxidation rather than other lipid pathways, such as ceramide synthesis, may also provide 321	
an explanation behind the lowered concentration of ceramides observed post-training.  322	
 323	
Previous investigations into the PLIN proteins in human skeletal muscle have predominantly focused 324	
on PLIN2 and PLIN5.  Less attention, however, has been paid to PLIN3, which is also expressed in 325	
skeletal muscle31.  Studies report either an increase19 or no change35 in PLIN3 protein content in whole 326	
muscle homogenates following MICT in obese individuals.  Here, we report for the first time that SIT 327	
and MICT leads to greater PLIN3 protein expression in both type I and type II fibres in obese 328	
individuals.  Like PLIN2 and PLIN5, acute endurance-type exercise in mice leads to an increase in 329	
PLIN3 mRNA abundance51.  In addition, PLIN3 expression in skeletal muscle was recently shown to 330	
be positively regulated by AMPK activity52, suggesting that exercise training will lead to greater PLIN3 331	
protein expression.  We also observed greater expression of both PLIN2 and PLIN5 in response to SIT 332	
and MICT in obese individuals, but interestingly the elevated expression of these proteins was specific 333	
to type I fibres.  With regards to PLIN2, it is notable that other studies investigating the effect of MICT 334	
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specifically in obese individuals have failed to observe an increase in the expression of this protein19, 35.  335	
This may be explained by the methodology used, since immunoblotting of whole muscle homogenates 336	
(as used in previous studies) does not take into account fibre type differences.  In line with the results 337	
of the present study, we previously reported that PLIN2 expression is upregulated specifically in type I 338	
fibres following MICT in obese type 2 diabetes patients37.  The increase in PLIN5 is consistent with 339	
other studies showing greater PLIN5 expression following MICT in obese individuals19, 35, and with our 340	
previous study demonstrating that SIT and MICT augment PLIN5 in lean individuals22.  Despite 341	
elevations in muscle PLIN protein abundance post-training, IMTG content and LD number did not 342	
increase significantly in the present study.  It is possible that the short duration of the training period 343	
may explain the lack of a significant increase in IMTG content, since 10 consecutive days of endurance-344	
type training also failed to increase IMTG content in obese individuals53.  Increases in IMTG content 345	
in obese individuals do occur following 12 to 16 weeks of MICT17, 18, 54.  Importantly, the fact that SIT 346	
and MICT augmented PLIN protein expression while IMTG content did not increase significantly, 347	
suggests that the increased PLIN abundance may be an early adaptation to exercise training in obese 348	
individuals and type 2 diabetes patients37. 349	
 350	
Greater PLIN expression following training is likely important to support a dynamic intramuscular lipid 351	
pool that can respond appropriately to changes in metabolic demand.  Indeed, evidence is accumulating 352	
to suggest that the PLIN proteins play a dual role in skeletal muscle, by 1) promoting IMTG storage 353	
under conditions of low metabolic demand, and 2) facilitating IMTG lipolysis and FA oxidation when 354	
metabolic demand increases.  Under basal conditions the PLIN proteins restrict lipolytic rates27, and for 355	
PLIN5 this is suggested to occur by preventing the binding of ATGL with its co-activator, CGI-58, on 356	
the LD surface55.  In accordance, overexpression of PLIN2 or PLIN5 in skeletal muscle augments TAG 357	
storage28, 29, whereas knockdown or knockout of PLIN2 or PLIN5 results in smaller and fewer LD, 358	
elevated rates of basal lipolysis, and a reduction in FA-induced TAG accumulation28, 30, 56.  PLIN3 may 359	
also play a similar role in muscle, since overexpression of PLIN3 in cultured myotubes exposed to 360	
palmitate augments IMTG storage52.  Evidence in the literature also points to a role for PLIN3 and 361	
PLIN5, and to a lesser extent PLIN2, in supporting IMTG lipolysis and FA oxidation under conditions 362	
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of increased metabolic demand.  Accordingly, myotubes overexpressing PLIN5 not only exhibit 363	
reduced rates of lipolysis and FA oxidation under basal conditions, but demonstrate greater rates of FA 364	
oxidation (compared to control cells) following stimulated lipolysis via either forskolin or contraction57.  365	
The suggestion that PLIN3 plays a role in IMTG oxidation comes from human studies reporting a 366	
positive association between PLIN3 expression and both whole-body fat oxidation33 and ex vivo 367	
palmitate oxidation33, 34.  Furthermore, in human muscle we have previously shown that PLIN236 and 368	
PLIN5-containing LD22 are preferentially broken down during moderate-intensity exercise compared 369	
to LDs with no PLIN2 or PLIN5 associated.  The PLIN proteins may also play a mechanistic role in the 370	
functional linkage between LDs and the mitochondrial network, since PLIN5 recruits mitochondria to 371	
the LD surface in cultured non-muscle cells leading to increased rates of mitochondrial β-oxidation in 372	
response to protein kinase A activation58.  In addition, both PLIN3 and PLIN5 have been reported to be 373	
present within mitochondria59, 60 and electrical contraction of rat skeletal muscle increases the content 374	
of PLIN5 in the mitochondrial fraction60.  We also observed a correlation between the number of LDs 375	
in contact with mitochondria and PLIN2, PLIN3 and PLIN5 expression in the present study.  Therefore, 376	
although the exact mechanisms involved in the functional linkage of LDs and mitochondria following 377	
exercise training remains unresolved, our data are supportive of a key role of the PLIN proteins in this 378	
process. 379	
 380	
The level of PLIN protein expression may also be important in mediating the concentration of muscle 381	
ceramides.  In support, PLIN2, PLIN3 and PLIN5 expression all were inversely related to muscle 382	
ceramides in the present study, and PLIN2 expression also demonstrated an inverse relationship with 383	
levels of Cer18:0.  There is evidence that the increase in PLIN5 expression may contribute to this, 384	
because PLIN5 overexpression in myotubes suppresses palmitate-induced ceramide accumulation57, 385	
whereas whole-body PLIN5 knock-out in mice leads to elevations in muscle ceramide30.  Therefore, 386	
our data suggest that PLIN5, and perhaps PLIN2 and PLIN3 are important for facilitating storage of 387	
FAs entering skeletal muscle into IMTG, rather than the FAs being used to synthesise DAG and/or 388	
ceramides.  This would theoretically improve skeletal muscle insulin sensitivity, and is in line with 389	
evidence that PLIN2 or PLIN5 overexpression improves (PLIN2) or maintains (PLIN5) insulin 390	
16 
	
sensitivity in rats fed a high-fat diet28, 29.  Furthermore, when PLIN2 was overexpressed, IMTG content 391	
was increased, but importantly no changes in DAG concentrations were observed28.  The increased 392	
expression of the PLIN proteins in the present study may therefore contribute to the lower ceramide 393	
concentrations observed following training. 394	
 395	
The observed changes in LD remodelling and reductions in Cer18:0 coincided with improvements in 396	
whole-body insulin sensitivity38.  Based on existing mechanistic studies30, 46, it is logical to link LD 397	
remodelling and reductions in ceramide levels with exercise training to the improvements in insulin 398	
action.  However, neither the changes in total ceramide or Cer18:0 correlated with the improvements in 399	
whole-body insulin sensitivity in the present study. While it is important to note that the current study 400	
is limited by the assessment of whole-body insulin sensitivity from an OGTT rather than direct 401	
assessment of muscle insulin sensitivity, our data do not support a direct link between lowered muscle 402	
ceramide concentrations and improvements in whole-body insulin sensitivity. Therefore, further work 403	
is required to determine the contribution of exercise-mediated adaptations in lipid handling to the 404	
improvements in skeletal muscle insulin sensitivity in obese individuals.  405	
 406	
In conclusion, this study has generated novel data that 4 weeks of exercise training increased the 407	
abundance of PLIN2, PLIN3 and PLIN5, led to greater spatial contact between LDs and the 408	
mitochondrial network, and reduced muscle ceramide concentrations.  These results add to the growing 409	
body of evidence that SIT and MICT improve lipid handling in skeletal muscle and counteracts the 410	
metabolic impairments that result from obesity and a sedentary lifestyle, with SIT offering a time-411	
efficient and effective alternative to MICT.  412	
 413	
 414	
 415	
 416	
 417	
 418	
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Figure legends 698	
 699	
Figure 1.  Training-induced changes in fibre-specific COX expression, IMTG, PLIN2, PLIN3 and 700	
PLIN5 content 701	
Immunofluorescence images of muscle sections were used to quantify muscle fibre type-specific COX 702	
expression (expressed as whole cell mean fluorescence intensity) (A, B).  Fibre-type specific content of 703	
IMTG (C, D), PLIN2 (E, F), PLIN3 (G, H) and PLIN5 content (expressed as % area stained) (I, J) was 704	
quantified from immunofluorescence images of muscle sections following selection of a uniform 705	
intensity threshold representative of positive signal.  Fibres stained positively for myosin heavy chain 706	
type I were classified as type I fibres, while those with no staining were classified as type II fibres.  707	
Values are presented as means ± S.E.M. (n=8 per group).  *Main fibre effect (P<0.05 vs. type I fibres).  708	
†Main training effect (P<0.05 vs. pre-training).  ‡Significant training effect within fibre (P<0.05 vs. pre-709	
training).   710	
 711	
Figure 2. Immunofluorescence images of IMTG, PLIN2, PLIN3 and PLIN5 712	
Representative images of IMTG, stained with oil red O, and PLIN2, PLIN3 and PLIN5 before and after 713	
4 weeks of SIT.  Right panels are corresponding images of myosin heavy chain I (MHC I) (stained 714	
green or red) in combination with wheat germ agglutinin Alexa Fluor 350 (WGA) to identify the cell 715	
border (stained blue) in skeletal muscle.  Positively stained fibres (green or red) are type I fibres, all 716	
other fibres are assumed to be type II fibres.  White bars represent 50 µm. 717	
 718	
Figure 3.  Effect of 4 weeks SIT or MICT on TEM-derived measures of mitochondria and lipids  719	
A: Representative image from one muscle fibre at x10,000 magnification, with light arrows indicating 720	
a lipid droplet and dark arrows indicating mitochondrial fragments.  Scale bar represents 2 µm. 721	
Representative image indicating a lipid droplet not in contact with a mitochondria fragment (B) and a 722	
lipid droplet in contact with a mitochondria fragment (C). B and C are at x40,000 magnification.  Scale 723	
bar represents 0.5 µm.  Mitochondria and lipid droplet physical characteristics, quantified from electron 724	
24 
	
microscopy images obtained before and after 4 weeks of SIT or MICT (D-J).  Values are means ± 725	
S.E.M. (SIT n=6, MICT n=7).  *Main training effect (P<0.05 vs. pre-training). 726	
 727	
Figure 4. Effect of 4 weeks SIT or MICT on muscle lipids 728	
Changes in muscle total TAG, DAG and ceramide concentrations in muscle in response to 4 weeks of 729	
SIT or MICT.  The concentration of TAG, DAG and ceramide was expressed relative to the 730	
concentration of phosphatidylcholine (PC), and was then used to calculate a fold change (relative to the 731	
value for MICT Pre) (n=7 per group).  *Main training effect (P<0.05 vs. corresponding Pre-Training 732	
value).       733	
 734	
Figure 5.  Effect of 4 weeks SIT or MICT on DAG and ceramides species 735	
Changes in individual DAG species (A), complex ceramides (MHC monohexosylceramide, DHC 736	
dihexosylceramide, THC trihexosylceramide, GM ganglioside) and sphingomyelin (SM) concentrations 737	
in muscle in response to 4 weeks of SIT or MICT (B).  Changes in the composition of individual 738	
ceramide (C) and THC (D) species were also quantified in response to SIT or MICT.  The concentration 739	
of each lipid species was expressed relative to the concentration of phosphatidylcholine (PC), and was 740	
then used to calculate a fold change (relative to the value for MICT Pre) (n=7 per group).  *Main training 741	
effect (P<0.05 vs. corresponding Pre-Training value).  †Trend for training effect (P=0.06 vs. 742	
corresponding Pre-Training value).  743	
1	
	
Supplementary Figure 1.  Effect of 4 weeks SIT or MICT on COX expression 1	
Representative images of COX staining before and after 4 weeks of SIT.  Right panels are corresponding 2	
images of myosin heavy chain I (MHC I) (stained green) in combination with wheat germ agglutinin 3	
Alexa Fluor 350 (WGA) to identify the cell border (stained blue) in skeletal muscle.  Positively stained 4	
fibres (green or red) are type I fibres, all other fibres are assumed to be type II fibres.  White bars 5	
represent 50 µm. 6	
 7	
Supplementary Figure 2.  Phosphatidylcholine concentrations before and after 4 weeks SIT or 8	
MICT 9	
Values are means ± S.E.M. (SIT n=6, MICT n=7).  Phosphatidylcholine (PC) concentration did not 10	
change from pre to post-training following either SIT or MICT. 11	
 12	
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